At the conclusion of this session, participants should:
As Medical Affairs teams we have evolved to become the “natural owners of scientific data across a product’s lifecycle” and are now poised to provide strategic medical direction to our organizations. In this dynamic and conversational webinar, we will review how adaptive connected technology and processes support our mandate to deliver integrated evidence that articulates clear clinical and economic value to improve patient experience and outcomes.
This Webinar will cover:
This session will provide a learning opportunity for our audience by describing:
A 2020 MAPS white paper highlights that while the metrics for departments such as R&D (new product approvals) and Commercial (sales) are clear, a single performance indicator that can measure the value of MA is lacking. While important metrics exist, such as time to publication submission and customer satisfaction, Share of Scientific Voice (SoSV) measures scientific impact and can serve as an objective and strategic performance metric for MA.
The measurement of SoSV is derived from the number of relevant mentions across scientific disseminations, relative to alternatives in the same therapeutic area. These clear outputs correlate with several activities that MA professionals lead across the MAPS-defined key pillars for MA - insights, evidence generation and evidence dissemination. This work is highly strategic and valuable for an organisation, as it shapes product strategy, closes data gaps, forms the scientific narrative and educates healthcare professionals. Therefore, SoSV provides a valuable metric for the performance and progress of MA.
This webinar will review the rationale for SoSV as a performance metric in MA, how it is implemented in practice, and examine how it can be used strategically to measure, prioritize and achieve success.
Events of the last 12 months have driven the pharmaceutical industry to more comprehensively examine how it can address ethnic and racial disparities in health outcomes and clinical research access. It is well accepted that diversity of clinical trial participants is essential to ensure that the trial population is truly representative of the patients who will use the therapy, yet disparities in clinical trial participation remain. A multi-faceted approach is required to understand the critical barriers to clinical research access for patients from diverse backgrounds.
During this thought-provoking webinar, our panel of internationally renowned Patient Advisors and Diversity Experts will share their perspectives on diverse representation in clinical trials and key barriers to research access, and explore solutions to address these critical issues.
This program will:
• Define health economics and outcomes research (HEOR) and its relationship to Medical Affairs
• Understand HEOR professional competencies included in the ISPOR Competency Framework, and which are most relevant to Medical Affairs professionals
• Discuss potential applications of the competencies by different stakeholders (employers, new professionals, students, academia)
• Identify ways for Medical Affairs professionals to further their HEOR knowledge and skills
This session will provide a learning opportunity for our audience by describing:
• An evolved Medical Communications function, by articulating the critical capabilities that make it a driver of strategic scientific communications aligned with overall medical imperatives
• A “Supernova” MA Therapeutic Area (strategy) and Medical Communications Team: An empowered Medical Communications department is a strategic partner to Therapeutic Area teams and exponentially increasing the value of MA deliverables
• The rationale and approach for developing a strategic Medical Communications Strategy and its components
Join this session to understand aligned HCP and patient education activities from the perspective of the current landscape, Medical Affairs support for aligned medical education and risk mitigation ensuring transparency, fairness and lawfulness.
• Explore the approach of aligning HCP education with patient education to optimize patient and healthcare outcomes
• Describe the different types of aligned HCP and patient education models
• Identify the risks and challenges of providing aligned HCP and patient education that is transparent, fair and lawful
In this module you will: review the changing role of Medical Affairs and how it has become a strong strategic partner in product launch excellence (LE); gain insights into the components of LE; identify processes, systems, and tools to support LE; utilize templates to support LE planning.